V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260016876 | 260009720 | 1.86 | 83.1 | Curative (C) | 2016-10-26 | 2016-11-05 | GEMCITABINE + TIP | 02 | N | 260029406 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260016877 | 260009722 | null | 85 | Adjuvant (A) | 2017-08-03 | 2017-08-03 | Cisplatin + Radiotherapy | 2 | N | 260029416 | DOCETAXEL + TRASTUZUMAB |
| 260016878 | 260009723 | 1.73 | 89.3 | null | 2015-01-14 | 2015-01-28 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | N | Y | 260029421 | VIP |
| 260016879 | 260009729 | 1.63 | 69.7 | Neo-adjuvant (N) | 2016-09-02 | 2016-09-02 | Brentuximab | N | N | 260029426 | CISPLATIN + EPIRUBICIN |
| 260016880 | 260009730 | 1.57 | null | Palliative (P) | 2014-11-11 | 2014-11-14 | CYCLOPHOSPHAMIDE | N | N | 260029427 | CYTARABINE HD + METHOTREXATE HD |
| 260016881 | 260018799 | 1.84 | 88.3 | Curative (C) | 2016-11-02 | 2016-12-28 | Cisplatin + Vinorelbine (IV) | N | N | 260029433 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260016882 | 260017008 | 1.88 | 81 | Curative (C) | 2017-10-27 | 2017-10-27 | ESHAP | N | N | 260029440 | DHAP - R |
| 260016883 | 260009733 | 1.74 | 71.1 | Disease modification (D) | null | 2016-07-02 | IPO | N | N | 260029442 | IVA |
| 260016884 | 260009735 | 1.58 | 79 | Curative (C) | null | 2017-08-31 | Bortezomib (weekly) | null | null | 260029448 | PEI |
| 260016885 | 260009737 | 1.59 | 48.9 | null | 2015-04-19 | 2015-04-29 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 2 | N | 260029461 | TRASTUZUMAB |
| 260016886 | 260009739 | 1.73 | 82 | Disease modification (D) | 2015-10-05 | 2015-10-05 | Cisplatin | N | N | 260029464 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260016887 | 260009742 | 1.63 | 67.6 | Disease modification (D) | 2018-03-27 | 2018-04-18 | CVP | N | N | 260029466 | CISPLATIN |
| 260016888 | 260017013 | 1.74 | 71.5 | Palliative (P) | 2016-01-11 | 2016-11-28 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260029472 | CARBOPLATIN + PACLITAXEL |
| 260016889 | 260009746 | 1.75 | 79 | Disease modification (D) | 2013-10-28 | 2013-10-29 | CISPLATIN + ETOPOSIDE + PACLITAXEL | N | Y | 260029477 | GEMCITABINE + OXALIPLATIN |
| 260016890 | 260009752 | 1.71 | 81.5 | Curative (C) | 2015-04-14 | 2015-08-28 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 2 | N | 260029507 | GEMCITABINE + OXALIPLATIN |
| 260016891 | 260009752 | 1.71 | 91.9 | Curative (C) | null | 2018-11-12 | Vinblastine weekly | Y | N | 260029507 | CISPLATIN + IFOSFAMIDE + MESNA + VINBLASTINE |
| 260016892 | 260009754 | 1.65 | 53.2 | Curative (C) | 2016-01-21 | 2016-03-10 | Pemetrexed | N | N | 260029509 | NIVOLUMAB |
| 260016893 | 260019260 | 1.63 | 48.9 | Adjuvant (A) | 2018-03-05 | 2018-03-19 | Cisplatin 7 day | 2 | N | 260029512 | CISPLATIN |
| 260016894 | 260009757 | 1.67 | 120.8 | null | 2016-11-21 | 2016-11-24 | EP | N | N | 260029513 | RMS 2005 TRIAL |
| 260016895 | 260009758 | 1.58 | 81 | Curative (C) | 2014-04-28 | 2014-04-28 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260029514 | METHOTREXATE |
| 260016896 | 260009762 | 1.66 | null | Curative (C) | null | 2015-12-07 | Carboplatin + Paclitaxel (3 weekly) | N | N | 260029525 | CVP |
| 260016897 | 260009764 | null | 74 | Curative (C) | 2015-06-11 | 2015-08-29 | Docetaxel | N | N | 260029528 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260016898 | 260009768 | 1.7 | 56.4 | Palliative (P) | 2019-12-11 | 2019-12-25 | REMODLB TRIAL | N | N | 260029532 | VINBLASTINE |
| 260016899 | 260018207 | 1.7 | 90 | Curative (C) | 2016-07-27 | 2016-07-27 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260029535 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260016900 | 260014645 | 1.58 | 94.2 | Palliative (P) | 2017-11-28 | 2017-12-07 | CYCLOPHOSPHAMIDE | N | N | 260029535 | LIPOSOMAL DOXORUBICIN |
| 260016901 | 260009774 | null | 101 | Curative (C) | 2017-02-24 | 2017-06-23 | ICE | N | null | 260029546 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260016902 | 260009775 | 1.79 | 55.3 | Curative (C) | 2016-08-31 | 2016-10-18 | BLEOMYCIN | N | N | 260029557 | CISPLATIN |
| 260016903 | 260009779 | null | 75 | Palliative (P) | 2016-07-28 | 2016-08-03 | ICE | 2 | N | 260029566 | TRASTUZUMAB |
| 260016904 | 260017023 | 1.67 | 0 | Curative (C) | 2018-05-18 | 2018-05-18 | ICE + GCSF | 02 | N | 260029568 | IFOSFAMIDE + PACLITAXEL |
| 260016905 | 260009781 | 1.76 | 81.5 | null | 2015-04-28 | 2015-06-01 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 02 | N | 260029570 | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 260016906 | 260009783 | 1.67 | 90 | Palliative (P) | 2018-06-25 | 2018-11-08 | ICE + GCSF | 02 | Y | 260029571 | IFOSFAMIDE + PACLITAXEL |
| 260016907 | 260009785 | 1.58 | 94.2 | Adjuvant (A) | 2017-02-23 | 2017-03-09 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260029587 | DOCETAXEL |
| 260016908 | 260009785 | 1.67 | 71.3 | Palliative (P) | null | 2017-06-20 | Temozolomide 200mg/m2 | N | N | 260029587 | CARBOPLATIN + PEMETREXED |
| 260016909 | 260009788 | 1.64 | 61 | Not known (9) | 2017-06-01 | 2017-06-02 | Carboplatin 21day + Paclitaxel 7day | 2 | N | 260029603 | ICE |
| 260016910 | 260014653 | 1.64 | null | null | 2018-03-22 | 2018-03-23 | BLEOMYCIN | N | N | 260029604 | CARBO + THIOTEPA + TOPOTECAN |
| 260016911 | 260009793 | 1.79 | null | Disease modification (D) | 2019-02-26 | 2019-02-28 | STS Rhabdomyosarcoma RMS 2005 VA | N | N | 260029617 | GEMCITABINE + TIP |
| 260016912 | 260009795 | 1.7 | 65.7 | Curative (C) | 2017-12-25 | 2018-01-01 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260029622 | IFOSFAMIDE + PACLITAXEL |
| 260016913 | 260009798 | 0 | 65.3 | Neo-adjuvant (N) | null | 2017-08-13 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260029627 | BLEOMYCIN + VINCRISTINE |
| 260016914 | 260009801 | 1.63 | 101.4 | null | 2014-08-27 | 2014-08-28 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260029642 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260016915 | 260009802 | 1.74 | 50 | Neo-adjuvant (N) | 2013-07-28 | 2013-07-28 | GEMCITABINE + TIP | 2 | N | 260029646 | PEMBROLIZUMAB |
| 260016916 | 260009805 | 1.88 | null | Disease modification (D) | 2018-04-24 | 2018-04-24 | Carboplatin + Thiotepa + Topotecan | N | N | 260029659 | BLEOMYCIN + VINCRISTINE |
| 260016917 | 260014661 | 1.72 | 61.2 | null | 2015-11-07 | 2016-02-29 | CVP | N | N | 260029660 | ICE |
| 260016918 | 260009810 | null | 69.7 | Curative (C) | 2016-06-12 | 2016-10-05 | GEMCITABINE + OXALIPLATIN + PACLITAXEL | N | N | 260029663 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260016919 | 260009811 | 1.69 | 67.3 | Adjuvant (A) | 2016-10-19 | 2016-10-20 | POMB | N | N | 260029667 | BLEOMYCIN |
| 260016920 | 260009813 | 1.69 | 103 | null | 2012-07-08 | 2012-11-17 | Vinblastine weekly | N | N | 260029667 | IVA |
| 260016921 | 260014666 | null | 71.3 | Curative (C) | 2017-05-16 | 2017-05-30 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL | Y | N | 260029688 | CARBOPLATIN + PACLITAXEL |
| 260016922 | 260009818 | 1.6 | 94.3 | Curative (C) | 2015-03-19 | 2015-03-24 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260029694 | CARBOPLATIN + PACLITAXEL |
| 260016923 | 260009819 | 1.63 | 96.2 | Palliative (P) | 2015-07-11 | 2015-07-11 | BLEOMYCIN + VINCRISTINE | 2 | N | 260029695 | BLEOMYCIN + VINCRISTINE |
| 260016924 | 260009821 | 1.58 | 65.9 | Palliative (P) | 2016-12-13 | 2016-12-15 | BLEOMYCIN + VINCRISTINE | 02 | N | 260029697 | CVP |
| 260016925 | 260009823 | 1.77 | 74 | null | 2017-09-04 | 2017-12-09 | GEMCITABINE + TIP | Y | Y | 260029713 | BLEOMYCIN + CISPLATIN + VINCRISTINE |